Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?
Abstract Background Alzheimer's Disease (AD), the most common type of dementia, is a chronic, progressive, and neurodegenerative brain discomfort that causes the be damage to brain cells. Although there is no definitive treatment for AD, various drug treatments are used to reduce and control the sym...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2023-08-01
|
| Edice: | Cost Effectiveness and Resource Allocation |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12962-023-00463-7 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|